States should form committee to negotiate Covid vaccine price: Chidambaram

Former Finance Minister P. Chidambaram on Friday termed the vaccine policy regressive and asked the states to form committees to negotiate price of the vaccines

Topics
Coronavirus Vaccine | Coronavirus | P Chidambaram

IANS  |  New Delhi 

Congress MP P Chidambaram at Parliament, during the Budget Session
Congress MP P Chidambaram

Former Finance Minister P. Chidambaram on Friday termed the vaccine policy regressive and asked the states to form committees to negotiate price of the vaccines.

"The central government's decision to allow multiple prices for vaccines is discriminatory and regressive. States must unanimously reject the decision," Chidambaram said.

He suggested that the best way forward is for the State governments to jointly form a Price Negotiation Committee and offer to negotiate a uniform price with the two vaccine manufacturers.

"The joint purchasing power of the State governments will force the manufacturers to agree to a uniform price. States must take the initiative. The central government has abdicated its responsibility and surrendered to corporate profiteering."

On Thursday Congress Interim President Sonia Gandhi wrote to Prime Minister Narendra Modi, alleging that the government has not learnt any lesson from the past and its vaccine policy is arbitrary and discriminatory.

In her letter to the Prime Minister, Sonia Gandhi said, "It's surprising that despite the harsh lessons of last year and pain inflicted to our citizens, the government continues to follow an arbitrary and discriminatory policy which promises to exacerbate existing challenges."

The Congress President said that the policy implies that the government has "abdicated" its responsibility for free vaccination to all.

She asked why the government is allowing profiteering by the companies manufacturing the vaccine in the country.

The Congress demanded that there should be free vaccination for all regardless of the economic condition and the policy should be reversed as there should be uniform pricing of the vaccine.

--IANS

miz/skp/

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Read our full coverage on Coronavirus Vaccine
First Published: Fri, April 23 2021. 09:44 IST
RECOMMENDED FOR YOU